Mukesh Chhanabhai

8.2k total citations · 3 hit papers
48 papers, 5.6k citations indexed

About

Mukesh Chhanabhai is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Mukesh Chhanabhai has authored 48 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pathology and Forensic Medicine, 30 papers in Oncology and 14 papers in Genetics. Recurrent topics in Mukesh Chhanabhai's work include Lymphoma Diagnosis and Treatment (41 papers), Viral-associated cancers and disorders (21 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Mukesh Chhanabhai is often cited by papers focused on Lymphoma Diagnosis and Treatment (41 papers), Viral-associated cancers and disorders (21 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Mukesh Chhanabhai collaborates with scholars based in Canada, United States and Germany. Mukesh Chhanabhai's co-authors include Randy D. Gascoyne, Joseph M. Connors, Kerry J. Savage, Laurie H. Sehn, Richard Klasa, Karamjit Gill, Tamara Shenkier, Judy Sutherland, C. P. Fitzgerald and Paul Hoskins and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Mukesh Chhanabhai

47 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

2006 1.0k citations Laurie H. Sehn, Brian Berry et al. Blood profile →
Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

2005 744 citations Laurie H. Sehn, Mukesh Chhanabhai et al. Journal of Clinical Oncology profile →
ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

2008 583 citations Kerry J. Savage, Joseph M. Connors et al. Blood profile →

Peers

Countries citing papers authored by Mukesh Chhanabhai

Since Specialization

Citations

This map shows the geographic impact of Mukesh Chhanabhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mukesh Chhanabhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mukesh Chhanabhai more than expected).

Fields of papers citing papers by Mukesh Chhanabhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mukesh Chhanabhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mukesh Chhanabhai. The network helps show where Mukesh Chhanabhai may publish in the future.

Co-authorship network of co-authors of Mukesh Chhanabhai

This figure shows the co-authorship network connecting the top 25 collaborators of Mukesh Chhanabhai. A scholar is included among the top collaborators of Mukesh Chhanabhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mukesh Chhanabhai. Mukesh Chhanabhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors 2013 ·Journal of Clinical Oncology ·Vivien Mak, (unknown), Mukesh Chhanabhai, Tamara Shenkier, Richard Klasa, Laurie H. Sehn, Diego Villa, Randy D. Gascoyne, Joseph M. Connors, Kerry J. Savage	286
2	Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP 2011 ·Journal of Clinical Oncology ·Laurie H. Sehn, David W. Scott, Mukesh Chhanabhai, Brian Berry, Anna Ruskova, Leanne Berkahn, Joseph M. Connors, Randy D. Gascoyne	146
3	Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494 2010 ·Clinical Cancer Research ·Jane N. Winter, Shuli Li, (unknown), Daina Variakojis, Beverly P. Nelson, Maryla Krajewska, Lijun Zhang, Thomas M. Habermann, Richard I. Fisher, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, Edie Weller, Ari Melnick, John C. Reed, Sandra J. Horning, Randy D. Gascoyne	26
4	Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma 2009 ·Cancer ·Maria Alma Rodriguez, Robert Pytlík, Tomáš Kozák, Mukesh Chhanabhai, Randy D. Gascoyne, Biao Lu, Steven R. Deitcher, Jane N. Winter	105
5	CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure 2009 ·Haematologica ·Nathalie A. Johnson, Stephen Leach, Bruce W. Woolcock, Ronald J. deLeeuw, Ali Bashashati, (unknown), Joseph M. Connors, Mukesh Chhanabhai, Angela Brooks‐Wilson, Randy D. Gascoyne	48
6	Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results 2008 ·Bone Marrow Transplantation ·Khaled M. A. Ramadan, Joseph M. Connors, Abdulwahab J. Al-Tourah, (unknown), Randy D. Gascoyne, Michael J. Barnett, Thomas J. Nevill, John D. Shepherd, S.H. Nantel, H.J. Sutherland, Donna L. Forrest, Donna E. Hogge, Julye C. Lavoie, (unknown), Mukesh Chhanabhai, Nicholas Voss, Ryan R. Brinkman, (unknown), Cynthia L. Toze	14
7	CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma 2007 ·Leukemia & lymphoma ·Kenneth S. Wilson, Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai, (unknown), Karamjit Gill, Richard Klasa, Brian Skinnider, Judy Sutherland, Joseph M. Connors, Randy D. Gascoyne	46
8	Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium 2007 ·Journal of Clinical Oncology ·Daphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, Philippe Gaulard, Wolfram Klapper, Abigail Lee, Birgitta Sander, Christoph Thorns, Elı́as Campo, Thierry Jo Molina, A. J. Norton, Anton Hagenbeek, Sandra J. Horning, Andrew Lister, John Raemaekers, Randy D. Gascoyne, Gilles Salles, Edie Weller	233
9	Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes 2006 ·Annals of Oncology ·(unknown), M. J. Barnett, (unknown), Mukesh Chhanabhai, Daniel L. Forrest, Donna E. Hogge, Julye C. Lavoie, SH Nantel, T.J. Nevill, JD Shepherd, Colin Smith, H.J. Sutherland, Cynthia L. Toze, (unknown), Joseph M. Connors	50
10	Lymphocytic Infiltration and Enlargement of the Lacrimal Glands 2005 ·Ophthalmology ·(unknown), (unknown), Valerie A. White, (unknown), Mukesh Chhanabhai, Jack Rootman	23
11	Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma 2005 ·Leukemia Research ·(unknown), Gwyn Bebb, Richard Klasa, Mukesh Chhanabhai, Valia S. Lestou, Douglas E. Horsman, Randy D. Gascoyne, Adrian Wiestner, Dana Masin, Marcel B. Bally, Michael E. Williams	27
12	Anaplastic large‐cell lymphoma presenting as acute leukemia 2005 ·American Journal of Hematology ·Bakul I. Dalal, Mukesh Chhanabhai, Douglas E. Horsman, (unknown), Robert Coupland	9
13	Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas 2005 ·Leukemia ·Stevan R. Knezevich, Olga Ludkovski, (unknown), (unknown), Mukesh Chhanabhai, Wan L. Lam, Richard Klasa, Joseph M. Connors, Martin J.S. Dyer, Randy D. Gascoyne, Douglas E. Horsman	29
14	Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6‐megabase region of 6q16–q21 2004 ·Genes Chromosomes and Cancer ·(unknown), Ichiro Okamoto, Valia S. Lestou, Olga Ludkovski, (unknown), Mukesh Chhanabhai, Randy D. Gascoyne, Richard Klasa, Joseph M. Connors, Marco A. Marra, Douglas E. Horsman, Wan L. Lam	20
15	Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification 2004 ·Annals of Oncology ·Kerry J. Savage, Mukesh Chhanabhai, Randy D. Gascoyne, Joseph M. Connors	270
16	Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes 2003 ·British Journal of Haematology ·Douglas E. Horsman, Ichiro Okamoto, Olga Ludkovski, Nhu Le, Lana Harder, Stefan Gesk, Reiner Siebert, Mukesh Chhanabhai, Laurie H. Sehn, Joseph M. Connors, Randy D. Gascoyne	85
17	t(2;5) Positive Lymphoma with Peripheral Blood Involvement 1998 ·Leukemia & lymphoma ·Mukesh Chhanabhai, Carolyn D. Britten, Richard Klasa, (unknown)	17
18	Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience 1998 ·Bone Marrow Transplantation ·(unknown), Mukesh Chhanabhai, (unknown), (unknown), (unknown), S.H. Nantel, Cynthia L. Toze, H-G Klingemann, HJ Sutherland, Donna E. Hogge, (unknown), Alan Le, (unknown)	83
19	Immunolocalization of the ICE/Ced-3–Family Protease, CPP32 (Caspase-3), in Non-Hodgkin's Lymphomas, Chronic Lymphocytic Leukemias, and Reactive Lymph Nodes 1997 ·Blood ·Stanisław Krajewski, Randy D. Gascoyne, Juan M. Zapata, Maryla Krajewska, Shinichi Kitada, Mukesh Chhanabhai, Douglas E. Horsman, Ken Berean, Lawrence D. Piro, Isabelle Fugier‐Vivier, Yong‐Jun Liu, Hong‐Gang Wang, John C. Reed	83
20	Immunohistochemical Analysis of Interleukin-1β–Converting Enzyme/Ced-3 Family Protease, CPP32/Yama/Caspase-3, in Hodgkin's Disease 1997 ·Blood ·Mukesh Chhanabhai, Stanisław Krajewski, Maryla Krajewska, Hong‐Gang Wang, John C. Reed, Randy D. Gascoyne	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact